Real-world data (RWD) has accumulated across the healthcare sector. Accessing it and then unlocking it is complicated, but artificial intelligence has made tremendous gains in helping researchers make sense of RWD. Then comes another obstacle: life science companies highly value RWD in their research but getting buy-in on AI remains elusive.

This trend report looks at how the integration of AI and RWD is set to advance drug discovery and patient care — and discusses strategies for overcoming skepticism.

This Industry Pulse report covers:

• How RWD paired with AI’s advanced analytics provides a richer view of patient experience and makes possible new insights.
• How AI-driven models are extracting real-world evidence from RWD to shape the future of urologic research.
• Approaches that shift AI skepticism to strategy in pharmaceutical development include addressing a spectrum of concerns.
• A platform that turns siloed RWD into actional insights that drive faster and better drug discovery.

​